AzTrials
AzTrials

Advance Care PlanningNCT04445896

The Responses Study

An observational study of Advance Care Planning, run by King's College London at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The issue Patients who are living with a life-limiting and progressive illness are often encouraged by the healthcare professionals looking after them to undergo a process called Advance Care Planning (ACP). Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Advance Care Planning
What is being tested?
Qualitative Interview
How many people
20 participants
Where
1 siteUnited Kingdom
Study dates
2 Mar 2022to 28 Feb 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients will be recruited from Princess Alice Hospice. Princess Alice is a large Hospice in Surrey which provides inpatient, day services and community services to 9 boroughs in South London, Surrey and Middlesex, with a catchment population of approximately 1 million people. Community home visit and outpatient services are provided by a Consultant led, multi-disciplinary team, and provide care to approximately 850 patients at any one time. Princess Alice has a 20 bedded Palliative Medicine inpatient unit and accepts referrals for symptom control and terminal care admissions, with a typical length of stay of 7-10 days. Patients are referred to Princess Alice Hospice for Specialist Palliative Care if they have a diagnosis of a life-limiting or life-threatening disease. Princess Alice Hospice provides holistic palliative care that is aimed to provide physical, psychological, spiritual and social support.

Who may be able to join

  • Aged 18 and over
  • A palliative care diagnosis confirmed by a referring healthcare professional, i.e. a diagnosis of a life-threatening or life-limiting illness
  • Have completed one or multiple ACP discussions as defined below, at any time prior to referral to study, with a healthcare professional
  • Sufficient cognitive capacity to provide informed consent and complete an interview
  • For the purposes of recruitment for this study, ACP is defined as:
  • Any significant discussion with a healthcare professional where patients have discussed their values, goals or preferences for future care. These can include discussions about wishes for further disease-modifying treatment, wishes for intensity of general medical care, preferred places of care and death, discussions around resuscitation and transfer to hospital, and completion of advanced directives. Healthcare professionals can include any doctor, nurse or allied health professional.

Who cannot join

  • Any patient the researcher has ever met or cared for in a clinical capacity, or knows in any other capacity
  • Any patient who has only had ACP discussions with a volunteer (trained or untrained) or non-healthcare professional
  • Inability to provide informed consent
  • Any patient deemed by the referring healthcare professional to be potentially too unwell or frail to undertake an interview

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Princess Alice Hospice

    Esher, Surrey, KT10 8NA

Other trials in United Kingdom

About this study

Official title: Exploring Patient Responses to Advance Care Planning: A Qualitative Study

The issue Patients who are living with a life-limiting and progressive illness are often encouraged by the healthcare professionals looking after them to undergo a process called Advance Care Planning (ACP). An advance care plan is a written guide of a patient's likes, dislikes, wishes, and the treatments they would want to refuse or the rituals they would want to follow - whether during illness or at the end of life. The planning process helps patients and their relatives think about different scenarios, and the plans that would be used by medical staff if that patient becomes too ill to communicate. ACP discussions can take many forms and are often described as a process.

It is accepted by healthcare professionals that ACP is useful to patients and their relatives. Research has also focussed on the positive nature of ACP, traditionally looking at issues such as how many patients have achieved their wishes and why, what makes ACP possible, and what prevents patients or healthcare professionals from starting these discussions. Some research has also looked at how patients experience the actual process of ACP itself.

Read more

However, there has been little research into the effect ACP discussions can have on a patient and their relatives, or how patients react to ACP discussions. As a result, researchers and healthcare professionals do not have a full understanding of the psychological impact on patients and their families, and any resulting changes in patients' outlook, emotional state, family and clinical relationships, and their behaviours.

Learning more about how patients respond to such important and challenging discussions about their care will be vital in improving healthcare professionals' understanding of how best to carry out ACP conversations, and how best to support patients and their relatives following ACP conversations. It is also important to explore not only the benefits of ACP but also the potential downsides or unexpected problems of having such a difficult conversation.

What the investigators will do The aim of this study is to explore how patients are affected by discussions about their future care, and if these discussions affect how patients think or feel in themselves and what they do. The investigators will conduct qualitative interviews with patients living with a life-limiting illness who have already had ACP discussions with a healthcare professional, to explore how and in what ways ACP discussions have affected patients and their families. Qualitative interviews are semi-structured interviews that are designed to explore issues and what these mean to people in-depth, in order to gather rich data that provides insight into a person's perspectives. They are well suited to exploring subjects about which little is yet known, and also subjects which can be sensitive or challenging.

Location of the study, and participation The study will be conducted from Princess Alice Hospice in Surrey, which provides both inpatient and community palliative care services to a large catchment population of approximately 1 million people, in South West London and Surrey.

The investigators aim to recruit 20 participants to represent a broad range of clinical and demographic characteristics, such as age, gender, ethnicity, diagnosis and borough in which they live, in order to explore the experiences of as diverse a group as possible. Participants will be interviewed in a place convenient for them, such as in their home or the Hospice.

Who the investigators are The study will be led by a clinician currently working in Palliative Care, as part of a Masters in Palliative Care, being undertaken at King's College London. The researcher will be supervised at all times by Dr. Katherine Bristowe and Dr. Lisa Brighton, of King's College London, who possess many years of experience in undertaking research among patients living with and dying from advanced disease, and their families.

Being tested
Qualitative Interview

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Qualitative InterviewOther

    Qualitative Interview to explore thoughts and feelings related to previous discussions around care at end of life

Study groups in NCT04445896
Study groupRoleWhat they receive
Study ParticipantsPatients with a diagnosis of a life-limiting illness who have previosuly had a discussion with a healthcare professional about the care they would want at the end of life
Receives: Other: Qualitative Interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Themes emerging from Qualitative Interview

    Key themes and concepts that emerge from multiple participants qualitative interviews that describe their experiences

    Measured: Throughout study completion, estimated to be 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2020
  2. Study start2 Mar 2022
  3. Primary completion20 Oct 2022
  4. Study completion28 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04445896
Sponsor's protocol ID
IRAS: 275766
Status last verified
Apr 2022
First submitted
9 Mar 2020
Last updated
3 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Advance Care Planning, run by King's College London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Themes emerging from Qualitative Interview (time frame: Throughout study completion, estimated to be 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in